期刊文献+

万古霉素类药物的临床合理用药综合评价分析 被引量:3

Comprehensive evaluation and analysis of clinical rational use of vancomycin drugs
下载PDF
导出
摘要 目的分析医院采用万古霉素类药物的合理用药综合评价体系。方法选择2015年3月-2017年3月医院收治的使用万古霉素的患者132例,建立并应用万古霉素类药物合理用药综合评价体系,对患者的用药情况进行评价,进而了解万古霉素类药物的使用情况。结果在用药剂量方面,患者治疗用药合理率为89.39%(118/132),预防用药合理率为74.24%(98/132)。在用药时间方面,常规临床用药时间为(7.84±2.15)d,手术预防用药时间为(9.12±3.25)d,用药时间合理率为90.91%(120/132)。在用药疗效方面,患者治疗有效率为72.73%(96/132),预防有效率为86.36%(114/132)。在用药安全方面,不良反应发生率为9.09%(12/132)。结论万古霉素类药物的合理用药综合评价体系能对药物使用情况准确评价,辅助合理用药,提高治疗效果。经评价,医院万古霉素类药物使用合理性情况较好,但仍需进一步加强规范。 Objective To analyze the comprehensive evaluation system of rational use of vancomycin in the hospital.Methods 132 patients with vancomycin admitted to the hospital from March 2015 to March 2017 were selected,and a comprehensive evaluation system for the rational use of vancomycin drugs was established and applied to evaluate the drug use of patients,and then understand the use of vancomycin drugs.Results In terms of dosage,the reasonable rate of treatment for patients was 89.39%(118/132),and the reasonable rate of preventive medication was 74.24%(98/132).In terms of medication time,the routine clinical medication time was(7.84±2.15)d,the surgical prophylaxis time was(9.12±3.25)d,and the rational time of medication was 90.91%(120/132).In terms of efficacy,the patient′s effective rate was 72.73%(96/132),and the preventive effective rate was 86.36%(114/132).In terms of medication safety,the incidence of adverse reactions was 9.09%(12/132).Conclusion The comprehensive evaluation system of rational use of vancomycin drugs can accurately evaluate the use of drugs,assist rational use of drugs,and improve the treatment effect.After evaluation,the rationality of vancomycin use in the hospital is relatively good,but it is still necessary to further strengthen the specification.
作者 韩琼 HAN Qiong(Department of Pharmacy ,The People's Hospital of Zigui, Hubei Province, Zigui 443600, China)
出处 《临床合理用药杂志》 2019年第13期5-6,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 万古霉素类药物 合理用药 综合评价体系 Vancomycin drugs Rational drug use Comprehensive evaluation system
  • 相关文献

参考文献10

二级参考文献72

  • 1抗菌药物临床应用指导原则[J].中国中医药现代远程教育,2005,3(2):13-15. 被引量:5
  • 2孙红,陈莎,段艺,艾洪武,胡红兵,游上游.血清胱抑素C在儿童肾脏疾病中的应用研究[J].微循环学杂志,2005,15(4):31-32. 被引量:40
  • 3马珍,吴丽娟.重症监护病房患者金黄色葡萄球菌感染及其耐药特征分析[J].国际检验医学杂志,2007,28(5):419-420. 被引量:13
  • 4RYBAK M,LOMAESTRO B,ROTSCHAFER JC,et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists,the Infectious Diseases Society of America,and the Society of Infectious Diseases Pharmacists[J].Am J Health Syst Pharm,2009,66(1):82-92. 被引量:1
  • 5TANAKA A,SUEMARU K,OTSUKA T,et al.Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function[J].Ther Drug Monit,2007,29(2):261-264. 被引量:1
  • 6FRYMOYER A,HERSH AL,BENET LZ,et al.Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate[J].Pediatr Infect Dis J,2009,28(5):398-402. 被引量:1
  • 7HAZLEWOOD KA,BROUSE SD,PITCHER WD,et al.Vancomycinassociated nephrotoxicity:grave concern or death by character assassination?[J].Am J Med,2010,123(2):182. 被引量:1
  • 8MEIER P,FROIDEVAUX C,DAYER E,et al.Cystatin C concentration and glomerular filtration rate[J].Lancet,2001,357(9256):634-635. 被引量:1
  • 9COLL E,BOTEY A,ALVAREZ L,et al.Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment[J].Am J Kidney Dis,2000,36(1):29-34. 被引量:1
  • 10Touchette MA,Patel RV,Anandan JV,et al.Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease[J].Am J Kidney Dis,1995,26(3):469-474. 被引量:1

共引文献60

同被引文献26

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部